Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hybrid peptides modulate the immune response

Hybrid peptides modulate the immune response

US Patent 7541334 · Granted Jun 2, 2009

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Therapeutic combinations comprising anti-CD123 immunoconjugates2023
Method for inducing an M1 dominated immune response and pharmaceutical compositi2022
Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies2018
Monospecific and bispecific anti-IGF-1R and anti-ERBB3 antibodies2017
Monospecific and bispecific anti-IGF-1R and anti-ErbB3 antibodies2016
II-key/antigenic epitope hybrid peptide vaccines2016
II-key/antigenic epitope hybrid peptide vaccines2016
Ii-key/HER-2/neu hybrid cancer vaccine2014
Ii-key/HER-2/neu hybrid cancer vaccine2014
Ii-key/antigenic epitope hybrid peptide vaccines2014
Ii-key/antigenic epitope hybrid peptide vaccines2014
Human papillomavirus / Ii-Key hybrids and methods of use2014